Skip To Main Content
Contact us
|
Help
Home
About
ADR
ADR Archives
Resources
Contact
Flash e-reader
Choose a chapter:
Introduction
Kidney
Pancreas
Liver
Intestine
Heart
Lung
Deceased Organ Donation
Allocation Policies
Appendix
Table Selection
Choose an organ:
All Organs
Kidney
Pancreas
Kidney/Pancreas
Heart
Lung
Heart/Lung
Intestine
Liver
Choose a group:
Choose a characteristic:
Requires
Adobe Acrobat Reader
Table 9.1a
Waiting List Patient Characteristics at End of Year
Liver Waiting List
Active Waitlist Patients, 2000 to 2009
Primary Diagnosis
Year
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
Total
13,915
14,888
13,056
12,645
12,678
12,745
12,495
12,222
12,238
12,442
Non-Cholestatic Cirrhosis
9,726
10,386
9,182
8,992
9,159
9,177
9,147
8,928
8,921
9,028
Cholestatic Liver Disease/Cirrhosis
1,624
1,656
1,481
1,418
1,362
1,358
1,315
1,205
1,169
1,197
Acute Hepatic Necrosis
706
729
627
605
536
505
461
405
349
328
Biliary Atresia
271
289
263
219
212
218
150
153
146
141
Metabolic Diseases
253
284
225
177
191
212
171
176
178
192
Malignant Neoplasms
180
199
147
169
177
197
227
281
354
452
Other
1,130
1,322
1,115
1,054
1,031
1,070
1,018
1,071
1,118
1,100
Unknown
25
23
16
11
10
8
6
3
3
4
Total (%)
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
Non-Cholestatic Cirrhosis
69.9%
69.8%
70.3%
71.1%
72.2%
72.0%
73.2%
73.0%
72.9%
72.6%
Cholestatic Liver Disease/Cirrhosis
11.7%
11.1%
11.3%
11.2%
10.7%
10.7%
10.5%
9.9%
9.6%
9.6%
Acute Hepatic Necrosis
5.1%
4.9%
4.8%
4.8%
4.2%
4.0%
3.7%
3.3%
2.9%
2.6%
Biliary Atresia
1.9%
1.9%
2.0%
1.7%
1.7%
1.7%
1.2%
1.3%
1.2%
1.1%
Metabolic Diseases
1.8%
1.9%
1.7%
1.4%
1.5%
1.7%
1.4%
1.4%
1.5%
1.5%
Malignant Neoplasms
1.3%
1.3%
1.1%
1.3%
1.4%
1.5%
1.8%
2.3%
2.9%
3.6%
Other
8.1%
8.9%
8.5%
8.3%
8.1%
8.4%
8.1%
8.8%
9.1%
8.8%
Unknown
0.2%
0.2%
0.1%
0.1%
0.1%
0.1%
0.0%
0.0%
0.0%
0.0%
Source: OPTN/SRTR Data as of October 1, 2010.
(%) = Percentages are based on totals including missing and unknown.
(-) = None in category.
Includes patients listed as active status at end of year.